Nyxoah SA
Develops hypoglossal neurostimulation therapy for Obstructive Sleep Apnea (OSA).
NYXH | BR
Overview
Corporate Details
- ISIN(s):
- BE0974358906
- LEI:
- 5493002O1ESKZ18OXR80
- Country:
- Belgium
- Address:
- Rue Edouard Belin 12, 1435 Mont-Saint-Guibert
- Website:
- https://www.nyxoah.com/
- Sector:
- Manufacturing
Description
Nyxoah SA is a medical technology company focused on the development and commercialization of solutions for Obstructive Sleep Apnea (OSA). The company's lead product is the Genio® system, a hypoglossal neurostimulation (HNS) therapy designed for patients with moderate to severe OSA. The system features a patient-centered, leadless, and battery-free implantable stimulator. It functions by providing bilateral stimulation to the hypoglossal nerve, which controls tongue muscles, to maintain an open airway during sleep.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-06-30 10:50 |
Nyxoah - ASM 2023 - Minutes - FR.pdf
|
French | 250.4 KB | ||
| 2023-06-27 22:30 |
2023 07 17 Transparency notification_RESMED_rectification 07.17.23.pdf
|
English | 771.7 KB | ||
| 2023-06-27 22:30 |
2023 07 27 - Press release - Number of shares (ENG).pdf
|
English | 153.6 KB | ||
| 2023-06-27 22:30 |
2023 07 27 - Press release - Number of shares (FR).pdf
|
French | 153.0 KB | ||
| 2023-05-16 22:05 |
Nyxoah Q1 2023 Financial Report ENG FINAL.pdf
|
English | 973.2 KB | ||
| 2023-05-16 22:05 |
Nyxoah Q1 2023 Financial Report FR FINAL.pdf
|
French | 666.7 KB | ||
| 2023-05-16 22:05 |
2023 05 16 22u05 Nyxoah Reports First Quarter 2023 Financial and Operating Resu…
|
English | 74.7 KB | ||
| 2023-05-16 22:05 |
2023 05 16 22u05 Nyxoah Reports First Quarter 2023 Financial and Operating Resu…
|
French | 77.2 KB | ||
| 2023-05-12 07:00 |
DOC 4 - Nyxoah - ASM 2023 - Proxy form - ENG FR.pdf
|
French | 322.8 KB | ||
| 2023-05-12 07:00 |
DOC 11 - Nyxoah - Board report statutory accounts 2022 - FR.pdf
|
French | 2.1 MB | ||
| 2023-05-12 07:00 |
DOC 10 - Nyxoah - Board report statutory accounts 2022 - ENG.pdf
|
English | 2.0 MB | ||
| 2023-05-12 07:00 |
DOC 5 - Nyxoah - ASM 2023 - Form for voting by mail - ENG FR.pdf
|
French | 287.7 KB | ||
| 2023-05-12 07:00 |
DOC 8 - Nyxoah - Statutory accounts 2022 - ENG.PDF
|
English | 1.0 MB | ||
| 2023-05-12 07:00 |
DOC 13 - Nyxoah - Auditor report statutory accounts 2022 - FR.pdf
|
French | 350.4 KB | ||
| 2023-05-12 07:00 |
DOC 14 - Nyxoah - Remuneration policy (submitted to ASM for approval).pdf
|
English | 262.3 KB |
Automate Your Workflow. Get a real-time feed of all Nyxoah SA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Nyxoah SA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Nyxoah SA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-11-19 | Laurette Renard | Close relation | Sell | 5,000 | 39,000.00 EUR |
| 2024-09-05 | Hambrecht Jürgen | Board | Sell | 980,000 | 6,840,400.00 EUR |
| 2024-09-05 | JH Capital GmbH | Close relation | Buy | 980,000 | 6,840,400.00 EUR |
| 2024-01-25 | Tompkins Patrick | Executive member | Buy | 2,000 | 18,020.00 USD |
| 2023-12-28 | Onkelinx Bruno | Executive member | Buy | 470 | 2,035.10 EUR |
| 2023-08-18 | Moreau Loïc | Executive member | Buy | 6,427 | 48,416.52 EUR |
| 2023-08-14 | Moreau Loïc | Executive member | Buy | 3,800 | 28,697.60 EUR |
| 2023-08-11 | Moreau Loïc | Executive member | Buy | 3,000 | 21,957.60 EUR |
| 2023-07-04 | Wildman Ventures LLC | Board | Buy | 25,000 | N/A |
| 2023-07-02 | Gianello Pierre | Board | Buy | 25,000 | N/A |
Peer Companies
